Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01316 | SPDP-PEG12-acid | |
| Inquiry | ||
| BADC-01317 | SPDP-PEG36-NHS ester | |
| Inquiry | ||
| BADC-01318 | SS-bis-amino-PEG4-NHS ester | |
| Inquiry | ||
| BADC-01319 | TCO-PEG1-Val-Cit-OH | |
| Inquiry | ||
| BADC-01322 | TCO-PEG3-aldehyde | |
| Inquiry | ||
| BADC-01323 | TCO-PEG3-Biotin | |
| Inquiry | ||
| BADC-01324 | TCO-PEG3-CH2-aldehyde | |
| Inquiry | ||
| BADC-01325 | TCO-SS-amine | |
| Inquiry | ||
| BADC-01327 | Tetrazine-PEG4-amine hydrochloride | 2752945-36-9 |
| Tetrazine-PEG4-amine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01329 | Tetrazine-PEG4-oxyamine hydrochloride | |
| Tetrazine-PEG4-oxyamine (hydrochloride) is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01330 | Tetrazine-PEG4-SS-NHS | |
| Inquiry | ||
| BADC-01331 | Tetrazine-PEG4-SS-Py | |
| Inquiry | ||
| BADC-01332 | Tetrazine-PEG5-SS-amine | |
| Inquiry | ||
| BADC-01333 | Tetrazine-PEG6-amine hydrochloride | |
| Tetrazine-PEG6-amine (hydrochloride) is a cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01334 | Tetrazine-Ph-OPSS | |
| Inquiry | ||
| BADC-01335 | Tetrazine-Ph-SS-amine | |
| Inquiry | ||
| BADC-01337 | Tetrazine-SS-PEG4-Biotin | |
| Inquiry | ||
| BADC-01951 | Solid Chemical phosphorylation reagent II | 202284-84-2 |
| Solid Chemical phosphorylation reagent II is a click chemistry reagent for the synthesis of oligonucleotides possessing 5'-terminal phosphate residues. | Inquiry | |
| BADC-00982 | Fmoc-N-amido-PEG2-acetic acid | 166108-71-0 |
| Fmoc-AEEA-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01934 | Docosanedioic acid | 505-56-6 |
| Behenic acid, or docosanedioic acid, a saturated fatty acid, is an effective emollient in the cosmetics industry due to its remarkable moisturizing properties. Behenic acid's therapeutic potential is another aspect of interest, as it has been researched for the treatment of various maladies, including multiple sclerosis and Parkinson's disease. Moreover, it is demonstrated to have a positive impact on chondrogenesis, which is vital for the formation of cartilage tissue due to its exceptional proliferative force. It is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry |
